Zandelisib hydrochloride
Zandelisib (ME-401) hydrochloride is a selective, orally active, non-covalent inhibitor of PI3Kδ. Zandelisib hydrochloride can sustainably inhibit AKT phosphorylation and downstream signaling pathways. Zandelisib hydrochloride can be used in the study of malignancies such as relapsed/refractory B-cell lymphoma.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 2839515-65-8
- Formule: C31H38F2N8O.xHCl
- Masse moléculaire:576.68 (free base)
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Description
In Vitro
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:SU-DHL-6 cells (1 × 107) were subcutaneously implanted into the right flank of 8-week-old male SCID mice[1]
-
Dosage:50, 100 mg/kg
-
Administration:p.o., once daily
-
Result:Achieved sustained PI3Kδ inhibitory effects.
Demonstrated significant tumor growth inhibition.
Maintained effective intracellular concentration in tumor tissues.
Essai clinique
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Chemical Information
-
CAS No. 2839515-65-8
-
Masse moléculaire 576.68 (free base)
-
Formule C31H38F2N8O.xHCl
-
SMILES
CN1CCC(C2=CC=CC=C2CC(NC3=NC(N4C5=CC=CC=C5N=C4C(F)F)=NC(N6CCOCC6)=N3)(C)C)CC1.Cl.[x]
-
Synonyms
ME-401 hydrochloride; PWT-143 hydrochloride
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)